Cargando…
LOXL1 and LOXL4 are novel target genes of the Zn(2+)-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells
BACKGROUND: EMT has been proposed to be a crucial early event in cancer metastasis. EMT is rigidly regulated by the action of several EMT-core transcription factors, particularly ZEB1. We previously revealed an unusual role of ZEB1 in the S100A8/A9-mediated metastasis in breast cancer cells that exp...
Autores principales: | Hirabayashi, Daisuke, Yamamoto, Ken-ichi, Maruyama, Akihiro, Tomonobu, Nahoko, Kinoshita, Rie, Chen, Youyi, Komalasari, Ni Luh Gede Yoni, Murata, Hitoshi, Gohara, Yuma, Jiang, Fan, Zhou, Jin, Ruma, I Made Winarsa, Sumardika, I Wayan, Yamauchi, Akira, Kuribayashi, Futoshi, Toyooka, Shinichi, Inoue, Yusuke, Sakaguchi, Masakiyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997211/ https://www.ncbi.nlm.nih.gov/pubmed/36910659 http://dx.doi.org/10.3389/fonc.2023.1142886 |
Ejemplares similares
-
Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2
por: Komalasari, Ni Luh Gede Yoni, et al.
Publicado: (2023) -
Histidine-Rich Glycoprotein Suppresses the S100A8/A9-Mediated Organotropic Metastasis of Melanoma Cells
por: Tomonobu, Nahoko, et al.
Publicado: (2022) -
Neuroplastinβ-mediated upregulation of solute carrier family 22 member 18 antisense (SLC22A18AS) plays a crucial role in the epithelial-mesenchymal transition, leading to lung cancer cells' enhanced motility
por: Bajkowska, Karolina, et al.
Publicado: (2020) -
Embigin Promotes Prostate Cancer Progression by S100A4-Dependent and-Independent Mechanisms
por: Ruma, I Made Winarsa, et al.
Publicado: (2018) -
Novel extracellular role of REIC/Dkk-3 protein in PD-L1 regulation in cancer cells
por: Gohara, Yuma, et al.
Publicado: (2023)